Huaming Tan

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

H. Bachelez, P.C.M. van de Kerkhof, Robert Strohal et al. · The Lancet · 2015 · 388 citations · Full text

Autoimmune Disease, Clinical Trials, Inflammatory Marker +7

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Kim Papp, Alan Menter, Bruce Strober et al. · British Journal of Dermatology · 2012 · 328 citations

The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment

Min Yao, Russell B. Smith, Michael M. Graham et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 188 citations

Radiation Therapy, Head-and-neck Cancer, Medicine +9

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience

Min Yao, Kenneth J. Dornfeld, John M. Buatti et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 188 citations · Full text

Intensity-modulated Radiation Treatment, Radiation Therapy, Iowa Experience +9

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Kim Papp, James G. Krueger, Steven R. Feldman et al. · Journal of the American Academy of Dermatology · 2016 · 151 citations · Full text